Aerie Pharmaceuticals, Inc. reiterated revenue guidance for the year 2022. The company is reiterating guidance for 2022 net product revenues of between $130 million and $140 million.
1st Jan change | Capi. | |
---|---|---|
+37.74% | 723B | |
+32.22% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.60% | 244B | |
+9.77% | 208B | |
-5.15% | 205B | |
+7.43% | 166B |